EUVIMEDEUVIMED entdecken
Crossref

Clinical features and prognostic factors of hospitalized patients with acute exacerbation of interstitial lung disease secondary to dermatomyositis/polymyositis

Cuirong Ba, Chunguo Jiang, Yanli Gao, Qiuhong Fang

Clinical Rheumatology · 2026-11 · 45 (11) · 6871-6879

DOI: 10.1007/s10067-026-08397-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 22.09.2026. Verfasst von Cuirong Ba und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China. Hauptthemen laut MEDLINE: Dermatomyositis, Lung Diseases, Interstitial, Polymyositis. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION/OBJECTIVES: Acute exacerbation of interstitial lung disease secondary to dermatomyositis or polymyositis (DM/PM-AEILD) is an intractable, life-threatening disease with unsatisfactory therapeutic efficacy, particularly in patients positive for anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody (Ab). Identifying prognostic risk factors for DM/PM-AEILD might help clinicians to stratify high-risk patients at an early stage and deliver targeted standardized treatment. METHODS: We retrospectively collected clinical data of 35 hospitalized patients diagnosed with DM/PM-AEILD, including 18 patients with anti-MDA5-Ab+ DM-AEILD. Clinical indicators were compared between survivors and non-survivors. Binary multivariate logistic regression was performed to screen independent risk factors for in-hospital mortality, and receiver operating characteristic (ROC) curves were drawn to evaluate predictive efficacy. Subgroup analyses were repeated for patients with anti-MDA5-Ab+ DM-AEILD. RESULTS: The cohort consisted of 21 females and 14 males; the mean age was 62.11 ± 10.78 years. The overall in-hospital mortality of DM/PM-AEILD reached 42.9%, and the mortality climbed to 66.7% among anti-MDA5 Ab+ subgroup. The clinical symptoms of DM/PM-AE-ILD were dominated by typical AE-ILD symptoms such as cough and respiratory failure. Peripheral blood CD4+T lymphocyte count exhibited the strongest predictive capacity for in-hospital death (OR = 0.987, cut-off = 373 cells/µL, AUC = 0.933). Model B combining pleural effusion, neutrophil percentage (N%), and C-reactive protein (CRP) ranked second (AUC = 0.923), followed by Model A integrating anti-MDA5 Ab+ and N% (AUC = 0.893). Decreased CD4+T lymphocyte count also presented favorable predictive performance for adverse prognosis in anti-MDA5 Ab+ DM-AEILD subgroup (OR = 0.990, AUC = 0.847). CONCLUSIONS: Patients hospitalized with DM/PM-AEILD suffer high in-hospital mortality, which is further elevated in anti-MDA5 Ab+ individuals. Reduced CD4⁺T lymphocyte count, anti-MDA5 Ab+, pleural effusion, elevated N%, and elevated CRP are independent adverse prognostic factors. Decreased CD4⁺ T lymphocyte count also predicts poor prognosis in patients with anti-MDA5 Ab+ DM-AEILD. Key Points • In DM/PM-AEILD hospitalizations, the in-hospital mortality rate was 42.9%; their symptoms exhibit characteristics of both AEILD and DM/PM (Beijing Chao-yang Hospital Inpatient Sample 2017.1-2022.6). • CD4⁺ T lymphocyte count, anti-MDA5 Ab⁺, pleural effusion, N%, and CRP independently predict in-hospital death, among which CD4⁺ T lymphocyte count has the highest predictive value. • Lower CD4⁺ T lymphocyte count indicates worse clinical outcomes in patients with anti-MDA5 Ab⁺ DM-AEILD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatomyositisLung Diseases, InterstitialPolymyositisHumansFemaleMaleMiddle AgedRetrospective StudiesPrognosisAgedHospital MortalityInterferon-Induced Helicase, IFIH1Disease ProgressionROC CurveRisk FactorsLogistic ModelsHospitalizationAutoantibodies

Stichwörter der Autor:innen

Anti-MDA5 antibodyDermatomyositisInterstitial lung diseasePolymyositis

Substanzen

Interferon-Induced Helicase, IFIH1IFIH1 protein, humanAutoantibodies

Autor:innen und Institutionen

  • Department of General Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
  • Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongren Tiyuchang South Road, Chaoyang District, Beijing, 100020, China.
  • Department of Radiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
  • Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongren Tiyuchang South Road, Chaoyang District, Beijing, 100020, China. fangmaster123@163.com.

Zitieren

APA

Ba, C., Jiang, C., Gao, Y., & Fang, Q. (2026). Clinical features and prognostic factors of hospitalized patients with acute exacerbation of interstitial lung disease secondary to dermatomyositis/polymyositis. Clinical Rheumatology, 45(11), 6871-6879. https://doi.org/10.1007/s10067-026-08397-0

Vancouver

Ba C, Jiang C, Gao Y, Fang Q. Clinical features and prognostic factors of hospitalized patients with acute exacerbation of interstitial lung disease secondary to dermatomyositis/polymyositis. Clinical Rheumatology. 2026;45(11):6871-6879. doi:10.1007/s10067-026-08397-0

BibTeX
@article{Ba2026,
  author = {Ba, Cuirong and Jiang, Chunguo and Gao, Yanli and Fang, Qiuhong},
  title = {Clinical features and prognostic factors of hospitalized patients with acute exacerbation of interstitial lung disease secondary to dermatomyositis/polymyositis},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {11},
  pages = {6871--6879},
  doi = {10.1007/s10067-026-08397-0}
}
Kostenlos starten →